TuHURA Biosciences, Inc. (HURA) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of TuHURA Biosciences, Inc. and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HURA
TuHURA Biosciences, Inc.
$1.96HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
LUCD
Lucid Diagnostics Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 3:30 PM EDT
Total return — HURA vs LUCD
growth of $100 · dividends reinvested · last 5yHURA -96.3% (-48.2%/yr)LUCD -95.0% (-45.0%/yr)LUCD compounded faster over this window
HURA LUCD
HURA vs LUCD: by the numbers
- •HURA is the larger company ($125M vs $115M market cap).
- •Both run net losses; HURA's is the smaller (0.00% vs -959.76% net margin).
Metrics side by side
Valuation
| Metric | HURA | LUCD |
|---|---|---|
| P/S ratio | N/A | 21.08 |
| P/B ratio | 6.85 | 10.50 |
Profitability
| Metric | HURA | LUCD |
|---|---|---|
| Gross margin | 0.00% | -60.26% |
| Operating margin | 0.00% | -1054.82% |
| Net margin | 0.00% | -959.76% |
| ROE | -165.57% | -478.26% |
| ROIC | -137.40% | -145.10% |
Growth (annualized)
| Metric | HURA | LUCD |
|---|---|---|
| Total return CAGR (5Y) | -45.49% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.